baber/WOPTO huggingface dataset:
Patent CA-3155821-A1 (CA)
Title: Accounting for errors in optical measurements
Inventor: PECKER SHARON
IPC: G06V20/69
Filed: 2020-10-22
Abstract: Apparatus and methods are described including placing at least a portion of a blood sample within a sample chamber (52), and acquiring microscopic images of the portion of the blood sample. Candidates of a given entity within the blood sample are identified, within the microscopic image. At least some of the candidates as being the given entity are validated, by performing further analysis of the candidates. A count of the candidates of the given entity is compared to a count of the validated candidates of the given entity, and at least the portion of the sample is invalidated from being used for performing at least some measurements upon the sample, at least partially based upon a relationship between the count of candidates and the count of validated candidates. Other applications are also described.
Patent CA-3160180-A1 (CA)
Inventor: DESROSIERS TONI MARIE
IPC: C09J7/21
Filed: 2022-05-25
Abstract: A tape is provided which is adherable in the absence of an adhesive layer and is water-resistant, the tape comprising a fabric layer which includes a first side and a second side and a mixture of beeswax, tree resin and jojoba oil, the mixture infusing the fabric layer and forming a first outer layer on the first side and a second outer layer on the second side, wherein the tape is between about a half inch to four inches in width and can be cut to length.
Patent CA-3164603-A1 (CA)
Inventor: YAZAWA RYO
IPC: F16K31/02
Filed: 2022-06-21
Abstract: A directional control valve includes: a housing having a cylindrical spool hole communicating with an inlet port letting a fluid from an external supply source at a predetermined pressure and an outlet port flowing the fluid to a working cylinder; a spool movable in the spool hole axially and changing an amount of flow of the fluid; a first solenoid driving section having a first needle coupled to or integral with a first end portion of the spool and driving the spool; and a second solenoid driving section having a second needle coupled to or integral with a second end portion of the spool and driving the spool, the directional control valve including a pressure equalization circuit equally applying a pressure to the end portions.
Patent CA-3167040-A1 (CA)
Title: Procedes de regulation de la dimension et du poids des grains
Inventor: LI YUNHAI
IPC: C12N9/12
Filed: 2021-02-08
Abstract: L'invention concerne des procédés d'augmentation de la dimension et/ou du poids des grains dans une plante, ainsi que des plantes présentant une dimension et/ou un poids des grains accrus.
Patent CA-3167789-A1 (CA)
Title: Durees de service configurables de transport a la demande
Inventor: BANTHIA PRACHIE
IPC: G01C21/34
Filed: 2021-02-10
Abstract: L'invention concerne des systèmes et des procédés de répartition d'une flotte de véhicules consistant à déterminer une durée totale attendue d'un trajet pour un véhicule. La durée totale attendue comprend une durée de service attendue différente d'une durée de déplacement pour le premier trajet. Le procédé consiste également à recevoir une ou plusieurs demandes d'un nouveau trajet et à déterminer, en fonction au moins en partie de la durée totale attendue du trajet, s'il convient d'attribuer le nouveau trajet au véhicule. Dans certains modes de réalisation, la durée de service attendue est déterminée en fonction de données historiques ou d'une préférence d'utilisateur. Dans certains modes de réalisation, la durée de service attendue est générée par un modèle entraîné à l'aide de données historiques.
Patent CA-3167939-A1 (CA)
Inventor: MACZUSZENKO ANDRZEJ
IPC: G01N21/03
Filed: 2021-02-12
Abstract: Spectrophotometric measurements on highly absorbing turbid samples face technical challenges that can be solved by reducing a path length of an optical chamber used during measurement. Reducing the path length requires exceptional control of variables that may be difficult to achieve in unit-use and inexpensive cuvettes. The invention provides a precise inexpensive method for producing an optical cavity useful in making spectrophotometric measurements on high attenuation liquid samples. Two components are shaped such that, when in contact, a central optical chamber and peripheral groove are formed. Liquid adhesive dispensed into the groove wicks around the interface perimeter, sealing the components together when cured. This results in a short precisely controlled path length that reduces chances of mechanical induced distortions (that arise with other bonding methods). The invention provides for manufacturing of a consistent optical chamber with very short path length within a diagnostic cartridge or cuvette.
Patent CA-3171158-A1 (CA)
Inventor: BEAUPREZ JOERI
IPC: C12P19/00
Filed: 2021-02-12
Abstract: The present invention relates to the technical field of synthetic biology and metabolic engineering. More particularly, the present invention relates to the technical field of fermentation of metabolically engineered microorganisms. The present invention describes engineered micro-organisms which produce oligosaccharides which are free of KDO-lactose impurities and/or KDO-oligosaccharide impurities.
Patent CA-3171774-A1 (CA)
Title: Substituted pyrimidine or pyridine amine derivative, composition thereof, and medical use thereof
Inventor: LIU LIFENG
IPC: A61K31/444
Filed: 2021-03-16
Abstract: Provided is a substituted pyrimidine or pyridine amine derivative represented by formula (I), and a pharmaceutically acceptable salt, solvate, stereoisomer, prodrug, and pharmaceutical composition thereof, as well as medical application thereof. The derivative has significant adenosine A2A receptor and/or adenosine A2B receptor antagonistic activities.
Patent CA-3171890-A1 (CA)
Inventor: RUBEN PETER CHARLES
IPC: A61P9/10
Filed: 2021-02-19
Abstract: L'invention concerne diverses compositions pharmaceutiques comprenant le nouvel agent thérapeutique cannabidiol qui intervient en faveur des canaux sodiques affectés négativement Nav1.5 et sert ainsi d'agent thérapeutique potentiel pour traiter divers troubles cardiaques. L'invention concerne également diverses compositions pharmaceutiques utilisant le nouvel agent thérapeutique cannabidiol pour supprimer ou réduire au minimum les effets secondaires d'autres agents thérapeutiques/médicaments qui induisent, ou qui sont susceptibles d'induire un QT long. L'invention concerne en outre une composition pharmaceutique de cannabidiol destinée à traiter ou à prévenir une inflammation induite par n'importe quel autre agent thérapeutique ou une inflammation induite par n'importe quelles maladies ou affections telles que la Covid-19, mais également une inflammation induite par n'importe quel vaccin, tel que le vaccin contre la Covid-19.
Patent CA-3173946-A1 (CA)
Inventor: STILLE MATS
IPC: H04L12/14
Filed: 2020-03-31
Abstract: L'invention concerne un procédé mis en ?uvre par un système multimédia IMS (140) d'un réseau de communication. Le procédé consiste à recevoir les informations d'un établissement d'appel ou d'une réception d'appel par un dispositif de communication sans fil (110), les informations comprenant un ID indiquant un abonné du dispositif de communication sans fil (110). Le procédé consiste également à : envoyer les informations de l'appel établi ou reçu à un système de facturation en ligne OCS (150), les informations comprenant l'ID indiquant l'abonné du dispositif de communication sans fil (110) ; recevoir, de l'OCS (150) et en réponse à l'envoi, un pointeur se référant à une image de notification ; et envoyer le pointeur au dispositif de communication sans fil (110). Il est possible ainsi pour un opérateur d'envoyer des images de notification à ses abonnés. L'invention concerne également des procédés mis en ?uvre par l'OCS (150) et le dispositif de communication sans fil (110).
Patent CA-3174124-A1 (CA)
Title: Nucleases guidees par arn et fragments actifs, variants associes et procedes d'utilisation
Inventor: BOWEN TYSON D
IPC: C12N15/113
Filed: 2021-04-23
Abstract: L'invention concerne des compositions et des méthodes de liaison à une séquence cible d'intérêt. Les compositions trouvent une utilisation dans le clivage ou la modification d'une séquence cible d'intérêt, la visualisation d'une séquence cible d'intérêt, et la modification de l'expression d'une séquence d'intérêt. Les compositions comprennent des polypeptides de nucléase guidée par ARN, des ARN CRISPR, des ARN CRISPR de trans-activation, des ARN guides et des molécules d'acide nucléique codant pour ceux-ci. L'invention concerne également des vecteurs et des cellules hôtes comprenant les molécules d'acide nucléique. L'invention concerne en outre des systèmes RGN pour lier une séquence cible d'intérêt, le système RGN comprenant un polypeptide de nucléase guidée par ARN et un ou plusieurs ARN guides.
Patent CA-3174206-A1 (CA)
Inventor: KIM JI CHUL
IPC: A61B5/378
Filed: 2021-09-08
Abstract: L'invention concerne des systèmes et des procédés pour le traitement du dysfonctionnement cognitif. Le système peut comprendre une source sonore, une source de lumière, un dispositif d'entrée et un système de stimulation neuronale qui récupère ou sélectionne un profil de stimulation. Le profil de stimulation peut comprendre un ou plusieurs morceaux de musique pour la lecture et un ou plusieurs motifs de stimulation rythmique ayant des paramètres variables, et des propriétés de signal variant dans le temps qui peuvent être accordées à la musique. Le système peut sélectionner les propriétés de signal de stimulation rythmique en se basant sur l'analyse de la musique, mesurer l'état physiologique du sujet, et ajuster davantage la stimulation rythmique sur la base des réponses neurales. Le système de stimulation neuronale peut lire les morceaux de musique sélectionnés pour diriger le son vers l'oreille, ou répondre à des sons musicaux ambiants détectés par un microphone, et régler les valeurs des paramètres et des propriétés variables du motif rythmique, construire un signal de sortie et délivrer un signal de sortie.
Patent CA-3174956-A1 (CA)
Inventor: BAKER GEOFF
IPC: E05F15/77
Filed: 2015-10-13
Abstract: The invention generally relates to a gateway device that operates as a hub or base station to provide for remote monitoring and control of a barrier operator such as is used to operate a powered garage door. The device includes a processor; a data storage device; a network interface for connecting the gateway device to a computer network; an operator interface for communicating with the barrier operator; and a computer program, which when executed on the processor:  permits access to the gateway device over the computer network by way of a mobile application installed on a mobile device;  transmits control signals received over the computer network to the barrier operator; and receives monitoring signals from the barrier operator.
Patent CA-3177159-A1 (CA)
Title: Methyltransferase nucleic acids and polypeptides
Inventor: WINZER THILO HANS
IPC: C12P17/00
Filed: 2011-06-16
Abstract: This disclosure relates to the isolation and sequencing of nucleic acid molecules that encode methyltransferase polypeptides from a Papaver somniferum cultivar; and uses in the production of noscapine and identification of poppy cultivars that include the genes that comprise said nucleic acid molecules.
Patent CA-3177456-A1 (CA)
Inventor: ASHMAN DANNY NATHAN
IPC: B60N3/00
Filed: 2021-05-21
Abstract: An example of an apparatus is provided. The apparatus includes a mount to secure in a vehicle. The mount includes a first lip to insert into a first gap and a first surface to brace against a first wall. The apparatus further includes an additional mount to secure in the vehicle. The additional mount includes a second lip to insert into a second gap and a second surface to brace against a second wall. The second gap is opposite the first gap and the second wall is opposite the first wall. Furthermore, the apparatus includes a support member supported by the mounts at each end. In addition, the apparatus includes a barrier structure supported by the support member wherein the barrier structure is to separate a first occupant of the vehicle from a second occupant of the vehicle.
Patent CA-3177916-A1 (CA)
Title: Heat transfer compositions of hydrofluorocarbons
Inventor: CHEN BENJAMIN BIN
IPC: C09K5/00
Filed: 2021-05-04
Abstract: The present invention relates to heat transfer compositions comprising 1-chloro-1,2 difluoroethylene for use in refrigeration, air conditioning, heat pump systems, chillers, and other heat transfer applications. The inventive heat transfer compositions can possess reduced global warming potential while providing good capacity and performance while providing preferable flammability characteristics
Patent CA-3182802-A1 (CA)
Title: Thermoplastic compositions, methods, apparatus, and uses
Inventor: COLGROVE JAMES R
IPC: C08K5/523
Filed: 2021-06-16
Abstract: Thermoplastic polyurethane (TPU) compositions, methods for producing TPU compositions, methods of using TPU compositions, and apparatuses produced therefrom are disclosed. Disclosed TPU compositions include a thermoplastic polyurethane polymer, a heat stabilizer, a flow agent, and a filler material. The filler may be a glass fiber. Disclosed TPU compositions have improved thermal stability and improved flow properties suitable for injection molding of articles of manufacture having a large plurality of fine openings or pores. Articles produced from the composition have superior thermal stability, abrasion resistance, and chemical resistance. Example articles include screening members for vibratory screening machines. Further embodiments include compositions without heat stabilizers, flow agents, and filler materials, and compositions in which two TPU materials having different harnesses are combined to generate a material with a pre-determined hardness. Injection molded screen elements having openings from 25 to 150 microns and open screening area from 10% to 35% are disclosed.
Patent CA-3186655-A1 (CA)
Inventor: KANOH Takeo
IPC: A61K31/337
Filed: 2021-07-21
Abstract: La présente divulgation concerne une composition qui contient, par exemple, du 2-(4-cyclopropyl-2-fluoroanilino)-3,4-difluoro-5-[[3-fluoro-2-méthyl-(méthysulfamoylamino)pyridin-4-yl]méthyl]benzamide ou un sel de qualité pharmaceutique de celui-ci, ou un solvate de qualité pharmaceutique du composé ou du sel, un dispersant (par exemple, de la méthylcellulose) et/ou un composé basique (par exemple, de la méglumine). La présente divulgation concerne une composition contenant un dérivé d'arylamide spécifique qui présente une activité de stabilisation du complexe RAF/MEK et/ou une activité inhibitrice sur MEK et qui est utile pour traiter ou prévenir des maladies à prolifération cellulaire, en particulier, le cancer. Cette composition présente d'excellentes caractéristiques concernant les propriétés de dissolution et/ou la stabilité du dérivé d'arylamide qu'elle contient.
Patent CA-3189456-A1 (CA)
Inventor: YANG XIAOBAO
IPC: C07D401/14
Filed: 2021-08-12
Abstract: Provided are a compound of formula (I) or a salt, an enantiomer, a stereoisomer, a solvate, and a polymorph thereof and an application thereof, and a pharmaceutical composition containing the compound of formula (I) or the salt, the enantiomer, the stereoisomer, the solvate, and the polymorph thereof which are used as active ingredients, and an application of the pharmaceutical composition. The compound can effectively prevent and/or treat diseases or symptoms associated with TNF-?.
Patent CA-3189697-A1 (CA)
Title: A piezoelectric resonator, a piezoelectric material for a piezoelectric resonator, and a method for manufacturing a piezoelectric resonator
Inventor: WALLINDER DANIEL
IPC: G01N29/02
Filed: 2021-09-22
Abstract: The present disclosure relates to piezoelectric resonator, a piezoelectric material for a piezoelectric resonator, and a method for manufacturing a piezoelectric resonator. In particular, it relates to piezoelectric resonator comprising a piezoelectric material, where the piezoelectric material is configured to have an improved shear wave velocity.
Patent CA-3190007-A1 (CA)
Title: Bismuth and cement method of abandoning a well and means of real time verification of the bismuth and cement placement process
Inventor: HEAD PHILIP
IPC: E21B33/12
Filed: 2021-08-23
Abstract: A method of abandoning a well, where the well is at least a length of tubing, and a first annulus outside the tubing, comprising the steps of puncturing a hole or holes in the tubing, the holes in the tubing giving access to the first annulus immediately outside the tubing, heating the inside of the tubing, depositing bismuth in proximity to the region inside the tubing which is heated, such that bismuth melts, the quantity of bismuth being sufficient that a first portion of the bismuth remains in the tubing, while a second portion of bismuth flows through the holes in the tubing into the first annulus, where it flows to the non-heated section allowing the bismuth to cool and solidify to form a plug in the tubing and the annulus.
Patent CA-3190852-A1 (CA)
Title: System for production of radioisotopes by bremsstrahlung comprising a curved converter
Inventor: GEETS JEAN-MICHEL
Filed: 2023-02-23
Abstract: The present invention concerns a system for converting an electron beam into a photon beam comprising, =    an electron accelerator (1) configured for generating an electron beam (10) of accelerated electrons along an irradiation axis (Z), =    a scanning unit (2) =    a focusing unit (3) for forming a focused beam (10f) converging towards a first focusing point (Fx) located on the irradiation axis (Z), =    a converting unit (4) located between the focusing unit (3) and the first focusing point (Fx), and comprising one or more bremsstrahlung converters (4.1-4.n), configured for converting the focused beam (10f) into a photon beam (11x), =    a target holder (5h) configured for holding a target (5), Characterized in that, the one or more bremsstrahlung converters (4.1-4.n) are curved such that the focused beam (10f) intersects each of the one or more bremsstrahlung converters (4.1-4.n) with an intersecting angle (a) comprised between 65  and 115  at all points, preferably between 75  and 105 at all points.
Patent CA-3193067-A1 (CA)
Inventor: YANG ZHIHONG JANE
IPC: C12N15/86
Filed: 2021-10-07
Abstract: L'invention concerne des procédés et des compositions de thérapie génique basée sur la plakophiline 2 pour le traitement de maladies cardiaques telles que la cardiomyopathie ventriculaire droite arythmogène (CVDA) ou la cardiomyopathie arythmogène (CMA).
Patent CA-3194853-A1 (CA)
Inventor: MELWIN EWIN RAMSTER
IPC: F24F11/30
Filed: 2023-03-31
Abstract: A heating, ventilation, and/or air conditioning (HVAC) system includes a variable capacity compressor and a controller communicatively coupled to the variable capacity compressor. The controller is configured to receive data indicative of an operating parameter of the HVAC system, determine an upper suction pressure limit of the HVAC system based on the data, determine a lower suction pressure limit of the HVAC system based on the data, determine a target suction pressure value, wherein the target suction pressure value is less than or equal to the upper suction pressure limit and is greater than or equal to the lower suction pressure limit, and modulate operation of the variable capacity compressor such that a detected suction pressure of the HVAC  system approaches the target suction pressure value.
Patent CA-3196724-A1 (CA)
Title: Therapeutic methods and compositions for treating pancreatic cancer using devimistat
Inventor: LUTHER SANJEEV
IPC: A61K31/4745
Filed: 2021-11-03
Abstract: The invention provides methods, compositions, and medical kits for treating pancreatic cancer using (i) devimistat in combination with (ii) modified FOLFIRINOX.
Patent CA-3197279-A1 (CA)
Inventor: WEYLAND TANIA
IPC: C08K3/105
Filed: 2021-10-28
Abstract: La présente invention concerne un procédé de stabilisation d?un matériau organique par réduction de la dégradation provoquée par un composé contenant du chlore. La présente invention concerne en outre un mélange stabilisant comprenant au moins un composé (A), au moins un absorbant UV et au moins un hydroxyde métallique. La présente invention concerne également une composition comprenant un matériau organique et le mélange stabilisant. En outre, la présente invention concerne un article préparé à partir de la composition. De plus, la présente invention concerne l?utilisation du mélange stabilisant pour stabiliser un matériau organique par réduction de la dégradation provoquée par un composé contenant du chlore.
Patent CA-3198856-A1 (CA)
Inventor: RUSANOVSKYY DMYTRO
IPC: H04N19/13
Filed: 2021-12-21
Abstract: A method of decoding video data comprises updating a coefficient statistic value based on one or more transform coefficients of a transform block (TB), wherein updating the coefficient statistic value comprises, for each respective transform coefficient of the one or more transform coefficients of the TB: performing a derivation process to determine a temporary value, wherein the derivation process is determined based at least in part on which encoding procedure of a plurality of encoding procedures is used to encode the respective transform coefficient, the plurality of encoding procedures including a context-based procedure for encoding the respective transform coefficient and encoding the respective transform coefficient as an absolute value; and setting the coefficient statistic value as an average of the coefficient statistic value and the temporary value; determining a history value based on the coefficient statistic value; determining a Rice parameter for a specific transform coefficient of the TB.
Patent CA-3205005-A1 (CA)
Inventor: PAHAN KALIPADA
IPC: A61K31/235
Filed: 2021-12-15
Abstract: The present disclosure generally relates to This disclosure relates to pharmaceutical compositions useful for inhibiting the progression of urea cycle disorders and neurodegenerative disorders, such as Huntington's disease, Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, Alzheimer's disease, multiple sclerosis, and amyotrophic lateral sclerosis. The pharmaceutical compositions may include glycerol tribenzoate and glycerol phenylbutyrate. The pharmaceutical compositions may be administered to the patient in any suitable manner, such as intranasally or orally.
Patent CA-3206968-A1 (CA)
Inventor: OKINO AYATOMO
Filed: 2018-09-21
Abstract: There are provided a developer accommodating portion for accommodating the developer, a discharge portion formed with a discharge opening for discharging the developer accommodated in the developer accommodating portion, and an engaging portion 30. The engaging portion 30 is engaged with an engaged portion 11 b with a mounting operation of a developer supply container 1 to displace a developer receiving portion 11 in an upward direction U so that the receiving opening communicates with the discharge opening. The engaging portion 30 has a holding portion 31 which is provided rotatably about a rotation shaft 41 and is provided with holding portion 21 to be engaged with the engaged portion 1 lb to hold the engaged portion 11b. With the mounting operation, the engaging portion 30 rotates about the rotation shaft 41 so that the engaged portion 11 b held by the holding portion 31 moves upward U.